Centogene Sees Large Increase in Short Interest
CNTG Stock | USD 0.11 0.02 22.22% |
Roughly 53% of Centogene's stockholders are presently thinking to get in. The analysis of overall sentiment of trading Centogene B V stock suggests that some investors are interested at this time. The current market sentiment, together with Centogene's historical and current headlines, can help investors time the market. In addition, many technical investors use Centogene B V stock news signals to limit their universe of possible portfolio assets.
Centogene |
Centogene was the target of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 4,000 shares, a growth of 11.1 percent from the February 28th total of 3,600 shares. Currently, 0.0 percent of the shares of the company are short sold. Based
Read at thelincolnianonline.com
Centogene Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Centogene can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Centogene Fundamental Analysis
We analyze Centogene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Centogene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Centogene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Centogene is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Centogene B V Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Centogene stock to make a market-neutral strategy. Peer analysis of Centogene could also be used in its relative valuation, which is a method of valuing Centogene by comparing valuation metrics with similar companies.
Peers
Centogene Related Equities
ACRS | Aclaris Therapeutics | 6.54 | ||||
XGN | Exagen | 3.39 | ||||
NOTV | Inotiv | 3.39 | ||||
STRRP | Star Equity | 2.73 | ||||
MDXH | MDxHealth | 2.04 | ||||
SERA | Sera Prognostics | 1.81 | ||||
PRE | Prenetics Global | 1.13 | ||||
BDSX | Biodesix | 0.70 | ||||
SHC | Sotera Health | 0.53 | ||||
FONR | Fonar | 0.49 | ||||
CSTL | Castle Biosciences | 0.53 | ||||
STRR | Star Equity | 3.29 | ||||
MYNZ | Mainz Biomed | 15.38 |
Complementary Tools for Centogene Stock analysis
When running Centogene's price analysis, check to measure Centogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Centogene is operating at the current time. Most of Centogene's value examination focuses on studying past and present price action to predict the probability of Centogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Centogene's price. Additionally, you may evaluate how the addition of Centogene to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |